Weicai Chen

1.3k total citations
32 papers, 726 citations indexed

About

Weicai Chen is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Weicai Chen has authored 32 papers receiving a total of 726 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 8 papers in Cancer Research and 6 papers in Oncology. Recurrent topics in Weicai Chen's work include RNA modifications and cancer (5 papers), Cancer-related molecular mechanisms research (4 papers) and RNA Interference and Gene Delivery (3 papers). Weicai Chen is often cited by papers focused on RNA modifications and cancer (5 papers), Cancer-related molecular mechanisms research (4 papers) and RNA Interference and Gene Delivery (3 papers). Weicai Chen collaborates with scholars based in China, United States and United Kingdom. Weicai Chen's co-authors include Xintao Shuai, Du Cheng, Jifeng Chen, Lu Wang, Yuanyuan Yuan, Xianming Wang, Yuanji Han, Wangjun Yuan, Xiaohui Wang and Xi Liu and has published in prestigious journals such as PLoS ONE, Cancer Research and Small.

In The Last Decade

Weicai Chen

31 papers receiving 716 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Weicai Chen China 15 495 157 117 112 91 32 726
Haisu Wan China 13 417 0.8× 124 0.8× 90 0.8× 67 0.6× 100 1.1× 30 596
Kai Kraemer Germany 15 488 1.0× 106 0.7× 95 0.8× 174 1.6× 83 0.9× 21 829
Qing Shi China 12 291 0.6× 115 0.7× 127 1.1× 102 0.9× 95 1.0× 39 602
Ju-Ock Nam South Korea 12 475 1.0× 113 0.7× 159 1.4× 85 0.8× 121 1.3× 15 810
Xiaoyuan Zi China 14 614 1.2× 163 1.0× 33 0.3× 125 1.1× 98 1.1× 20 909
Arnab Ghosh United States 18 445 0.9× 183 1.2× 73 0.6× 103 0.9× 201 2.2× 27 746
Guangqiang Li China 16 489 1.0× 183 1.2× 35 0.3× 92 0.8× 61 0.7× 24 830
Zhaowei Xu China 15 294 0.6× 99 0.6× 59 0.5× 134 1.2× 82 0.9× 28 547
Laura D. Nelson United States 14 604 1.2× 230 1.5× 128 1.1× 69 0.6× 113 1.2× 27 1.1k
Caixia He China 12 433 0.9× 124 0.8× 82 0.7× 61 0.5× 84 0.9× 21 812

Countries citing papers authored by Weicai Chen

Since Specialization
Citations

This map shows the geographic impact of Weicai Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weicai Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weicai Chen more than expected).

Fields of papers citing papers by Weicai Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weicai Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weicai Chen. The network helps show where Weicai Chen may publish in the future.

Co-authorship network of co-authors of Weicai Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Weicai Chen. A scholar is included among the top collaborators of Weicai Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weicai Chen. Weicai Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ou, Yangwen, Qiao Zuo, Weicai Chen, et al.. (2025). Stage-specific requirement for METTL3-dependent m6A epitranscriptomic regulation during myogenesis. Communications Biology. 8(1). 1317–1317.
2.
Luo, Yi, Jia-Dong Zhang, Xiaochuan Zhao, et al.. (2025). Simplifying the protocol for low-pollution-risk, efficient mouse myoblast isolation and differentiation. PubMed. 3(1). 8–8. 1 indexed citations
3.
Sun, Hao, Zhuo Zhang, Tianda Li, et al.. (2023). Live‐cell imaging reveals redox metabolic reprogramming during zygotic genome activation. Journal of Cellular Physiology. 238(9). 2039–2049. 3 indexed citations
4.
Chen, Chiqi, Yaping Zhang, Li Xie, et al.. (2022). NADPH metabolism determines the leukemogenic capacity and drug resistance of AML cells. Cell Reports. 39(1). 110607–110607. 13 indexed citations
5.
Chen, Weicai, Shuning Liu, Yi Yang, Zhuo Zhang, & Yuzheng Zhao. (2022). Spatiotemporal monitoring of NAD+ metabolism with fluorescent biosensors. Mechanisms of Ageing and Development. 204. 111657–111657. 4 indexed citations
6.
Liu, Zhe, et al.. (2022). Identification of a seven-gene prognostic signature using the gene expression profile of osteosarcoma. Annals of Translational Medicine. 10(2). 53–53. 8 indexed citations
7.
Xie, Shu‐Juan, Shuang Tao, Li‐Ting Diao, et al.. (2021). Characterization of Long Non-coding RNAs Modified by m6A RNA Methylation in Skeletal Myogenesis. Frontiers in Cell and Developmental Biology. 9. 762669–762669. 18 indexed citations
8.
Chen, Chiqi, Yaping Zhang, Li Xie, et al.. (2021). NADPH Metabolism Determines the Leukemogenic Capacity and Drug Resistance of AML Cells. SSRN Electronic Journal. 1 indexed citations
10.
Zhang, Zhuo, Weicai Chen, Yuzheng Zhao, & Yi Yang. (2018). Spatiotemporal Imaging of Cellular Energy Metabolism with Genetically-Encoded Fluorescent Sensors in Brain. Neuroscience Bulletin. 34(5). 875–886. 17 indexed citations
11.
Chen, Weicai, Ye Kuang, Haibo Qiu, et al.. (2017). Dual Targeting of Insulin Receptor and KIT in Imatinib-Resistant Gastrointestinal Stromal Tumors. Cancer Research. 77(18). 5107–5117. 28 indexed citations
12.
Yuan, Jianhui, et al.. (2016). miRNA-411 acts as a potential tumor suppressor miRNA via the downregulation of specificity protein 1 in breast cancer. Molecular Medicine Reports. 14(4). 2975–2982. 23 indexed citations
13.
Chen, Weicai, et al.. (2016). [Effect of Total Ravonoids of Herba Epimedium on BMP-2/RunX2/OSX Signaling Pathway during Osteogenic Differentiation of Bone Marrow Mesenchymal Stem Cells].. PubMed. 36(5). 614–8. 1 indexed citations
14.
Yang, Peipei, Weicai Chen, Xuhui Li, et al.. (2016). Downregulation of cyclin D1 sensitizes cancer cells to MDM2 antagonist Nutlin-3. Oncotarget. 7(22). 32652–32663. 18 indexed citations
15.
Yang, Jianbo, Weicai Chen, Huisheng Wu, et al.. (2015). Molecular Features of Triple Negative Breast Cancer: Microarray Evidence and Further Integrated Analysis. PLoS ONE. 10(6). e0129842–e0129842. 17 indexed citations
16.
Wu, Tianlong, et al.. (2015). Nontraumatic posterior atlantooccipital dislocation associated with atlantoaxial instability. European Spine Journal. 24(S4). 619–622. 4 indexed citations
17.
Chen, Weicai, et al.. (2015). Efficacy of TCH/TEC neoadjuvant chemotherapy for the treatment of HER-2-overexpressing breast cancer. Oncology Letters. 9(4). 1922–1926. 11 indexed citations
18.
Li, Jingguo, Du Cheng, Tinghui Yin, et al.. (2013). Copolymer of poly(ethylene glycol) and poly(l-lysine) grafting polyethylenimine through a reducible disulfide linkage for siRNA delivery. Nanoscale. 6(3). 1732–1740. 78 indexed citations
19.
He, Jinsong, Xianming Wang, Hong Guan, et al.. (2011). Clinical efficacy of local targeted chemotherapy for triple-negative breast cancer. Radiology and Oncology. 45(2). 123–8. 7 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026